Verona Pharma plc CEO David Zaccardelli's 2022 pay jumps 361% to $5.2M
Verona Pharma plc reports 2022 executive compensation
By ExecPay News
Published: March 21, 2023
Verona Pharma plc reported fiscal year 2022 executive compensation information on March 21, 2023.
In 2022, three executives at Verona Pharma plc received on average a compensation package of $3.8M, a 384% increase compared to previous year.
Average pay of disclosed executives at Verona Pharma plc
David Zaccardelli, Chief Executive Officer, received $5.2M in total, which increased by 361% compared to 2021. 80% of Zaccardelli's compensation, or $4.1M, was in stock awards. Zaccardelli also received $497K in non-equity incentive plan, $525K in salary, as well as $28K in other compensation.
Mark W. Hahn, Chief Financial Officer, received a compensation package of $4.8M, which increased by 546% compared to previous year. 84% of the compensation package, or $4M, was in stock awards.
Kathleen Rickard, Chief Medical Officer, earned $1.5M in 2022, a 170% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 21, 2023.